Here's What Key Metrics Tell Us About BeOne Medicines Ltd. - Sponsored ADR (ONC) Q4 EarningsZacks Investment Research • 02/26/26
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology LeadershipBusiness Wire • 02/26/26
BeOne Medicines to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26Business Wire • 02/11/26
BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/13/26
Is the Options Market Predicting a Spike in BeOne Medicines Stock?Zacks Investment Research • 01/07/26
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEABusiness Wire • 01/06/26
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 12/23/25
BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular CarcinomaBusiness Wire • 12/18/25
Senhwa Biosciences and BeOne Medicines Announces a Clinical Supply Agreement to Address the Challenge of Cold TumorsPRNewsWire • 12/10/25
BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic LeukemiaBusiness Wire • 12/08/25
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell MalignanciesBusiness Wire • 12/07/25
U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell LymphomaBusiness Wire • 11/26/25
This Pharma Stock Owned By Top Fund Flirts With Entry As Earnings Surge 452%Investors Business Daily • 11/21/25
BeOne Medicines AG (ONC) Presents at Jefferies London Healthcare Conference 2025 TranscriptSeeking Alpha • 11/17/25
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal AdenocarcinomaBusiness Wire • 11/17/25
Biotech Leader BeOne Medicines Eyes New Buy Point As Cancer Drug Sales SurgeInvestors Business Daily • 11/11/25
BeOne Medicines AG (ONC) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference TranscriptSeeking Alpha • 11/11/25